Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dillon, Laura W
1358  Ergebnisse:
Personensuche X
?
1

Persistent IDH mutations are not associated with increased ..:

Ravindra, Niveditha ; Dillon, Laura W. ; Gui, Gege...
Bone Marrow Transplantation.  59 (2024)  3 - p. 428-430 , 2024
Link: https://doi.org/10.1038/..
 
?
2

TP53 mutation screening for patients at risk of myeloid mal..:

Mukherjee, Devdeep ; Lawal, Rialnat A. ; Fitzhugh, Courtney D...
Leukemia.  38 (2024)  7 - p. 1604-1608 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Measurable residual disease in patients undergoing allogene..:

Wong, Zoë C. ; Dillon, Laura W. ; Hourigan, Christopher S.
Best Practice & Research Clinical Haematology.  36 (2023)  2 - p. 101468 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Prediction of HLA genotypes from single-cell transcriptome ..:

Solomon, Benjamin D. ; Zheng, Hong ; Dillon, Laura W....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Pembrolizumab and decitabine for refractory or relapsed acu..:

Goswami, Meghali ; Gui, Gege ; Dillon, Laura W...
Journal for ImmunoTherapy of Cancer.  10 (2022)  1 - p. e003392 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Utility of plasma cell-free DNA for de novo detection and q..:

Gutierrez-Rodrigues, Fernanda ; Beerman, Isabel ; Groarke, Emma M....
Haematologica.  107 (2021)  8 - p. 1815-1826 , 2021
Link: https://doi.org/10.3324/..
 
?
7

Microtransplantation in older patients with AML: A pilot st..:

Sung, Anthony D. ; Jauhari, Shekeab ; Siamakpour‐Reihani, Sharareh...
American Journal of Hematology.  95 (2020)  6 - p. 662-671 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Highly multiplexed proteomic assessment of human bone marro..:

Çelik, Haydar ; Lindblad, Katherine E. ; Popescu, Bogdan...
Blood Advances.  4 (2020)  2 - p. 367-379 , 2020
Link: https://doi.org/10.1182/..
 
?
9

Next‐generation sequencing for measurable residual disease ..:

Ghannam, Jack ; Dillon, Laura W. ; Hourigan, Christopher S.
British Journal of Haematology.  188 (2019)  1 - p. 77-85 , 2019
Link: https://doi.org/10.1111/..
 
?
10

Molecular Measurable Residual Disease Testing of Blood Duri..:

Wong, Hong Yuen ; Sung, Anthony D. ; Lindblad, Katherine E....
Frontiers in Oncology.  8 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
11

Pathogenic TERT promoter variants in telomere diseases:

Gutierrez-Rodrigues, Fernanda ; Donaires, Flávia S. ; Pinto, André...
Genetics in Medicine.  21 (2019)  7 - p. 1594-1602 , 2019
Link: https://doi.org/10.1038/..
 
?
12

DNA Fragile Site Breakage as a Measure of Chemical Exposure..:

Lehman, Christine E. ; Dillon, Laura W. ; Nikiforov, Yuri E..
Carcinogenesis.  , 2017
Link: https://doi.org/10.1093/..
 
?
13

Production of Extrachromosomal MicroDNAs Is Linked to Misma..:

Dillon, Laura W. ; Kumar, Pankaj ; Shibata, Yoshiyuki...
Cell Reports.  11 (2015)  11 - p. 1749-1759 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Role of DNA secondary structures in fragile site breakage a..:

Dillon, Laura W. ; Pierce, Levi C. T. ; Ng, Maggie C. Y..
Human Molecular Genetics.  22 (2013)  7 - p. 1443-1456 , 2013
Link: https://doi.org/10.1093/..
 
?
15

DNA Topoisomerases Participate in Fragility of the Oncogene..:

Dillon, Laura W. ; Pierce, Levi C. T. ; Lehman, Christine E....
PLoS ONE.  8 (2013)  9 - p. e75741 , 2013
Link: https://doi.org/10.1371/..
 
1-15